BIOCONNSEBiocon Limited· PharmaceuticalsLowNeutral
Announced Thu, 17 Jul · 14:08 IST

Biocon Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 08, 2025

Board & Shareholder Meetings View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has notified the stock exchanges about its 47th Annual General Meeting (AGM) scheduled for Friday, August 08, 2025, at 3:30 PM IST, to be held via video conferencing. E-voting will be open from August 03 to August 07, 2025, with the cut-off date set as August 01, 2025. The record date for the final dividend is July 04, 2025, and payment will be made on or before August 22, 2025, with the Board proposing a final dividend of ₹0.50 per share. The Integrated Annual Report for FY25 highlights consolidated total income of ₹164,699 million ($1.95 billion), up 5%, with EBITDA of ₹43,745 million and net profit of ₹10,133 million. The Biosimilars segment contributed 58% of revenue at ₹90,174 million, while Generics and Research Services grew 8% and 4% respectively. Biocon also raised ₹45 billion via a QIP in June 2025 to strengthen the balance sheet.

Likely market impact

Shareholders should note the July 04, 2025 record date to be eligible for the final dividend of ₹0.50 per share, with payment expected by August 22, 2025. The AGM and accompanying annual report provide a comprehensive view of FY25 performance and the company's strategic direction across biosimilars, generics, and research services, which may influence investor sentiment ahead of the meeting.